Moderna Covid recordings can take up to 6 weeks: WHO


The Moderna vaccine uses mRNA technology and is being introduced in many countries.

Geneva, Switzerland:

World Health Organization experts on Tuesday cautiously endorsed the delay in the second injection of the Moderna coronavirus vaccine in some situations, as was the case with the Pfizer BioNTech bursts.

The WHO Strategic Advisory Group on Immunization Experts (SAGE) also insisted that international travelers should not be given priority for Covid-19 shocks for the time being.

During a meeting last week, the experts discussed the Moderna vaccine, which, like the Pfizer BioNTech vaccine, uses mRNA technology and is being introduced in a number of countries.

Both vaccines require boosters after three to four weeks, but several countries with limited vaccine supplies have announced that they will delay the second injection so more people can get the first dose.

The WHO vaccine advisory group said it was best to stick to the tested 28-day intervals between doses.

However, earlier this month it was said that in “exceptional circumstances” it would be possible to wait up to 42 days for the second dose of the Pfizer BioNTech vaccine to be administered, and this was also said on Tuesday for the Moderna bursts.

However, it cautioned that “the evidence is not strong” and stressed that “SAGE does not recommend cutting the dose in half”.

The UN Department of Health has only approved the Pfizer BioNTech emergency vaccine so far, but it is expected that approval for the Moderna sting will also be granted soon.

SAGE also recommended Tuesday that the Moderna vaccine, such as the Pfizer BioNTech vaccine, only be given in environments where a potential anaphylactic reaction could occur.


It said it couldn’t recommend its use during pregnancy or breastfeeding without seeing further safety data.

Given the global shortage of various Covid-19 vaccines, the experts also advised against giving priority to vaccinating international travelers.

WHO calls for health workers and the most vulnerable 20 percent of people in each country to receive Covid-19 shocks before expanding vaccination programs to other populations.

“In the current era of very limited vaccine supplies, preferential vaccination for international travelers would be contrary to the principle of justice,” said SAGE.

“For this reason, and due to the lack of evidence that vaccination reduces the risk of transmission, SAGE is not currently recommending Covid-19 vaccination for travelers,” it said.

However, it added that, of course, people in risk groups who wish to travel should be included in vaccination programs.

(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)


Please enter your comment!
Please enter your name here